The COVID vaccine success story as a springboard for future research CIDRAP

The harmonized approach and broad database created by the COVID-19 Prevention Network (CoVPN), or Operation Warp Speed (OWS), to rapidly develop life-saving SARS-CoV-2 vaccines can be harnessed for future research on other public health threats that require a speedy response, according to a special communication published yesterday in JAMA Network Open.

...

Only 1% of immune-impaired US adults have gotten the recommended 5 COVID vaccine doses CIDRAP

Only 41% of US adults with impaired immune systems, who are at high risk for poor COVID-19 outcomes, have received four doses of mRNA vaccine, and less than 1% had received the recommended five doses as of August, according to a study published late last week in JAMA Network Open.

...

How often do you need a COVID booster shot? Yearly, new data suggests. Yale researchers have found people need annual COVID-19 booster shots to prevent or slow down outbreaks. Here's what to know. YahooNews

Healthy people should get annual COVID-19 boosters to prevent widespread outbreaks, a new study from Yale University suggests.

Yearly shots provide just enough frequency to prevent huge outbreaks, while not putting an undo burden on people.

Moderna, Pfizer’s new race: The RSV vaccine FDA approval process

...

Pfizer’s vaccine is already in the FDA approval process and Moderna CEO Stéphane Bancel told CNBC from Davos on Wednesday that it will be filing for FDA approval for its vaccine soon — it even had a plan in place for top executives to be ready to submit over the holidays if needed.

ALSO SEE: Moderna says its RNA vaccine was nearly 84% effective in preventing symptoms in adults 60 and older

...